Theravance Biopharma (TBPH) Asset Utilization Ratio: 2014-2025
Historic Asset Utilization Ratio for Theravance Biopharma (TBPH) over the last 12 years, with Sep 2025 value amounting to 0.19.
- Theravance Biopharma's Asset Utilization Ratio rose 8.48% to 0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19, marking a year-over-year increase of 8.48%. This contributed to the annual value of 0.17 for FY2024, which is 50.68% up from last year.
- As of Q3 2025, Theravance Biopharma's Asset Utilization Ratio stood at 0.19, which was down 4.84% from 0.20 recorded in Q2 2025.
- Theravance Biopharma's Asset Utilization Ratio's 5-year high stood at 0.20 during Q2 2025, with a 5-year trough of 0.06 in Q4 2022.
- Its 3-year average for Asset Utilization Ratio is 0.16, with a median of 0.17 in 2024.
- In the last 5 years, Theravance Biopharma's Asset Utilization Ratio plummeted by 74.15% in 2021 and then soared by 143.42% in 2023.
- Theravance Biopharma's Asset Utilization Ratio (Quarterly) stood at 0.14 in 2021, then crashed by 58.30% to 0.06 in 2022, then skyrocketed by 143.42% to 0.14 in 2023, then climbed by 25.58% to 0.18 in 2024, then climbed by 8.48% to 0.19 in 2025.
- Its last three reported values are 0.19 in Q3 2025, 0.20 for Q2 2025, and 0.19 during Q1 2025.